NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR
DISSEMINATION IN THE UNITED STATES
TORONTO, Oct. 3, 2012 /CNW/ - Centric Health Corporation ("Centric
Health" or "the Company") (TSX: CHH), Canada's leading diversified
healthcare services company, today announced it has completed the sale
of an additional 2,500 convertible unsecured subordinated notes (the
"Notes") at a price of $1,000 per Note for additional gross proceeds of
$2.5 million, pursuant to the over-allotment option granted in
connection with its bought-deal offering which closed on September 21,
2012. The exercise of the over-allotment option brings the total number
of Notes sold by Centric Health pursuant to its bought-deal Notes
financing to 27,500 and the total gross proceeds to $27.5 million
($25.9 million net of fees and expenses).
The offering was underwritten by a syndicate of underwriters led by
National Bank Financial Inc.
For further information please refer to the Company's complete filings
at www.sedar.com.
No securities regulatory authority has either approved or disapproved of
the contents of this news release. The securities being offered have
not been, and will not be, registered under the United States
Securities Act of 1933, as amended (the ''U.S. Securities Act''), or
any state securities laws, and may not be offered or sold in the United
States unless pursuant to an exemption therefrom. This press release is
for information purposes only and does not constitute an offer to sell
or a solicitation of an offer to buy any securities of Centric Health
in any jurisdiction.
About Centric Health
Centric Health's vision is to be Canada's premier healthcare company,
providing innovative solutions centered on patients and healthcare
professionals. As a diversified healthcare company with investments in
several niche service areas, Centric Health currently has operations in
medical assessments, disability and rehabilitation management,
physiotherapy and surgical centres, homecare, specialty pharmacy,
wellness and prevention and home medical equipment. With knowledge and
experience of healthcare delivery in international markets and
extensive and trusted relationships with payers, physicians, and
government agencies, Centric Health is pursuing expansion opportunities
into other healthcare sectors to create value for all stakeholders
through an unwavering commitment to the highest quality of care.
Centric Health's common shares are listed on the TSX under the symbol
CHH, and Centric Health's Notes issued under this Offering will be
listed on the TSX under the symbol CHH.NT. For further information,
please visit www.centrichealth.ca and www.lifemark.ca. Centric Health's strategic advisor is Global Healthcare Investments &
Solutions ("GHIS") (www.ghis.us). GHIS and entities controlled by shareholders of GHIS are currently
the largest shareholders of Centric Health.
This press release contains statements that may constitute
"forward-looking statements" within the meaning of applicable Canadian
securities legislation. These forward-looking statements include, among
others, statements regarding business strategy, plans and other
expectations, beliefs, goals, objectives, information and statements
about possible future events. Readers are cautioned not to place undue
reliance on such forward-looking statements. Forward-looking statements
are based on current expectations, estimates and assumptions that
involve a number of risks, which could cause actual results to vary and
in some instances to differ materially from those anticipated by
Centric Health and described in the forward-looking statements
contained in this press release. No assurance can be given that any of
the events anticipated by the forward-looking statements will transpire
or occur or, if any of them do so, what benefits Centric Health will
derive there-from.
SOURCE: Centric Health Corporation